Dr. Aria Vazirnia

HONORS & AWARDS • Resident grant recipient from American Society for Laser Medicine & Surgery (ASLMS) (2018) • Outstanding Achievement in Doctoral Education in Medicine, Association of Professors & Scholars of Iranian Heritage (2015) • NIH TL1 Research Training Grant (2013-2014) • NIH Short-term Research Training Grant (2011) • Thomas A. and Virginia Ehrisman Research Scholarship (2009-2010) • UCLA Dean’s Honor List (for every undergraduate quarter) • UCLA College Honors (2010) • UCLA Phi Beta Kappa Honors (2010) • UCLA Alpha Lambda Delta & Phi Eta Sigma Honors (2007) LEADERSHIP • Resident/Fellow Board Representative, American Society for Laser Medicine & Surgery (ASLMS) (2018-2020) • Resident Board, California Society of Dermatology & Dermatologic Surgery (CalDerm) (2017-2019) • Resident Liaison, American Society for Dermatologic Surgery (ASDS) (2017-2019) • Online Education Material Review Committee, American Society for Laser Medicine & Surgery (ASLMS) (2018- 2020) • Reviewer, Lasers in Surgery & Medicine (2020-present) • Reviewer, Cureus Journal of Medical Science (2020-present) 7218 Rock Ridge Ter ¨ West Hills, CA 91307 ¨ (818) 451-9657 ¨ ariavazir@gmail.com • Reviewer, Journal of Dermatologic Nurses’ Association (2016-present) • Residency interviewing committee, Olive View - UCLA internal medicine residency program (2015-2016) • Medical school interviewing committee, UC San Diego School of Medicine (2013-2014) RESEARCH EXPERIENCE • Wellman Center for Photomedicine/MGH: Investigating the effects of lidocaine in the biological properties of basal cell carcinoma, 2019-present Advisor: R. Rox Anderson, MD • UC San Diego Dermatology: Investigating new dermal cooling devices for treating benign pigmented lesions, 2017-2019 Advisor: Arisa Ortiz, MD • UC San Diego Dermatology: Investigating the use of short-pulsed 1064nm Nd:YAG lasers in the treatment of rosacea, 2016-2019 Advisor: Arisa Ortiz, MD • UC San Diego Dermatology: Sub-investigator for a number of randomized controlled trials, including clinical trials for dupilumab in adults with moderate-to-severe atopic dermatitis Advisors: Tissa Hata, MD & Richard Gallo, MD PhD • UC San Diego Clinical & Translational Research Institute: Graduate program in clinical research theory & design, 2013-2014 • UC San Diego School of Medicine: Studying the effect of comorbid disease on survival in patients with advanced head and neck cancer, 2011-2012 Advisor: Loren Mell, MD • UCLA Dermatology: Investigating the role of vitamin D in innate immunity, 2007-2010 Advisors: Philip T. Liu, PhD & Robert Modlin, MD PUBLICATIONS • Vazirnia A, Avram MM (2020). Cryolipolysis. In Carniol, Avram, & Brauer (Eds.), Complications in Minimally Invasive Facial Rejuvenation: Prevention and Management (pp. 169-173). In Press: Thieme Medical Publishers, Inc. • Vazirnia A, Braz A, Fabi SG. Nonsurgical jawline rejuvenation using injectable fillers. J Cosmet Dermatol. 2019 Dec 31. • Vazirnia A, Wat H, Danesh MJ, Anderson RR. Intense pulsed light for improving dry eye disease in rosacea. J Am Acad Dermatol. 2019 Dec 3. pii: S0190-9622(19)33137-8. • Danesh MJ, Vazirnia A, Anderson RR. Diode laser for the use of lingual venous malformations. J Am Acad Dermatol. 2019 Dec 3. pii: S0190-9622(19)33135-4. • Vazirnia A, Schneider J, Ortiz A. Treatment of benign adnexal tumors in Birt-Hogg-Dubé Syndrome with surgical debulking in combination with fractional and fully ablative carbon dioxide laser resurfacing. Dermatol Surg. 2019 Aug 22. • Vazirnia A, Ortiz AE. Treatment of benign pigmented lesions using a novel Dermal Cooling System. Lasers Surg Med. 2018 Nov 27. • Bari O, Vazirnia A, Cohen PR, Romero LS: Genitogluteal Porokeratosis in an HIV-Positive Man: A Case Report and Review of the Literature on Genital Porokeratosis. Dermatol Online J. Mar 2018; 24(3). • Zavala K, Vazirnia A, Liu PT (2017). Vitamin D and Innate Immunity. Vitamin D Health, Disease and Therapeutics. 4th ed. Academic Pr. Print. • Loh T, Vazirnia A, Afshar M, Dorschner R, Paravar T. Continuity of Care in Dermatology Residency Programs in the United States. Dermatol Online J. May 2017;23(5):2. • Vazirnia A, Jacob SE. Teledermatology Viewpoint: Reticulated Violaceous Eruption. JDNA. May/June 2017;9(3):148-149. • Vazirnia A, Zumwalt M, Jacob SE. Syphilis: A review of the history, clinical features, and management. Dermatology in Practice. 2016;22(4):100-104. • Vazirnia A, Cohen PR. Poland's Syndrome: A Concise Review of the Clinical Features Highlighting Associated Dermatologic Manifestations. Am J Clin Dermatol. 2015 Aug;16(4):295-301. • Vazirnia A, Jacob SE. The language of dermatology: cutaneous manifestations and management of syphilis. JDNA. 2015 Feb; 7(1):56-59. • Vazirnia A, Jacob SE. A review of the American Contact Dermatitis Society’s Allergen of the Year: 2000-2015. The Dermatologist. Nov 2014: http://www.the-dermatologist.com/content/review-acds%E2%80%99-allergen-od-year-2000- 2015 • Raju S, Vazirnia A, Totri C, Hata TR. Treatment of merkel cell carcinoma of the head and neck: a systematic review. Dermatol Surg. 2014 Oct;40(12):1273-1283. • Vazirnia A, Cohen PR. Acitretin for the management of generalized cutaneous lichen planus. Dermatol Online J. 2014 Sep 16;20(9). • Zakeri K, MacEwan I, Vazirnia A, Cohen EEW, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. Race and competing mortality in advanced head and neck cancer, Oral Oncology, 2014 Jan;50(1):40-4. • Vazirnia, A. & Liu, P.T. (2012). Vitamin D and the innate immune response. In A.A. Litonjua (Ed.), Vitamin D and the Lung: Mechanisms and Disease Associations (pp. 59-84). New York: Humana Press. Print. • Liu PT, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, Ferguson B, Mehta MD, Vazirnia A, Rea TH, Sarno EN, Graeber TG, Modlin RL. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med. 2012 Jan 29;18(2):267-73. • Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, Wheelwright M, Vazirnia A, Zhang X, Steinmeyer A, Zugel U, Hollis BW, Cheng G, Modlin RL. Convergence of IL-1b and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE. 2009 June 5; 4(6):e5810. ORAL PRESENTATIONS • Vazirnia, A., Ortiz, A. (2018). Treatment of Benign Pigmented Lesions Using a Novel Pre-Beta Dermal Cooling System: Clinical Utility and Patient Experiences at a University-based Practice. Oral Presentation presented at: 2018 ASLMS Annual Conference; Dallas, TX. • Vazirnia, A., Schneider, J. (2017). Birt-Hogg-Dube syndrome. Oral Presentation presented at: 2017 San Diego Dermatology Society Meeting - University of California, San Diego; San Diego, CA. • Vazirnia, A., Dohil, M., Matiz, C. (2016). Legius Syndrome. Oral Presentation presented at: San Diego Dermatology Society – Rady Children’s Hospital; San Diego, CA. • Vazirnia, A., Hou Z., Admani, S., Romero, L., Nelson, F. (2016). Lupus Pernio. Oral Presentation presented at: 2016 San Diego Dermatology Society Meeting – University of California, San Diego; San Diego, CA. POSTER PRESENTATIONS • Vazirnia A, Ortiz A. The use of the short-pulsed 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser in the treatment of flushing and background erythema in rosacea. Poster presented at: AAD Annual Meeting, Feb 2018; San Diego, CA, USA. • David CG, Ojeda VD, Vazirnia A, Nelson A, Ortiz A. UCSD Clean Slate: free tattoo removal program for adult probationers. Poster presented at: ASDS Meeting, October 2017; Chicago, Illinois, USA. • Vazirnia A, Ortiz A. Treatment of background erythema in rosacea with the 1064-nm neodymium-doped yttrium aluminum garnet laser: two cases. Poster presented at: CalDerm Meeting, September 2017; Santa Barbara, California, USA. • Vazirnia A, Lee WW, Orme C. A case of vascular access steal syndrome presenting as painful extremity ulcerations. Poster presented at: CalDerm Meeting, September 2017; Santa Barbara, California, USA. • Loh T, Vazirnia A, Afshar M, Dorschner R, Paravar T. Evaluation of continuity clinic structure in dermatology residency programs in the United States and Canada. Journal of the American Academy of Dermatology. 2015 May; Volume 72, Issue 5, Supplement 1, AB93 • Loh T, Vazirnia A, Afshar M, Dorschner R, Paravar T (2015). Factors associated with dermatology resident continuity clinics. Poster presented at: 23rd World Congress of Dermatology Meeting, November 2014; Vancouver, Canada. • Loh T, Vazirnia A, Afshar M, Dorschner R, Paravar T (2014). Survey on the format of and satisfaction with continuity clinic in dermatology residency training. Poster presented at: Association of Professors of Dermatology (APD) Annual Meeting, September 2014; Chicago, IL. • Vazirnia A, MacEwan I, Zakeri K, Vokes E, Weichselbaum R, Mell L. (2012). The effect of race on competing mortality in advanced head and neck cancer. Poster presented at: NIH Summer Scholars Poster Session; La Jolla, CA. • Vazirnia A, Liu P, Wheelwright M, Modlin R (2010). The role of microRNA in mycobacterial disease and the innate immune response. Poster presented at: UCLA Undergraduate Research Scholars Program Poster Session; Los Angeles, CA. COMMUNITY OUTREACH • Dermatology resident director, “Clean Slate” tattoo removal project, UC San Diego 2016-2019 • Volunteer, Free Skin Cancer Screening Program (Spotme®), San Diego, CA 2018-2019 • Volunteer, “Stand Down” program, Department of Veterans Affairs, San Diego, CA 2014-2019 • Volunteer, Dermatology Specialty Clinic, Free Clinic Project, UC San Diego 2013-2019 • Volunteer, General Clinic, Free Clinic Project, UC San Diego 2010-2012 • UCSD SOM representative, National Psoriasis Foundation 2013-2019 • UCSD SOM representative, National Marrow Donor Program (NMDP) 2010-2012 • International volunteer, International Service Learning medical team, Jaumave, MX 2008 PROFESSIONAL ASSOCIATIONS • AAD, ASDS, ASLMS, CalDerm, SD Dermatologic Surgical Society, ACP, AMSA LANGUAGES • English & Persian (native fluency)